Загрузка...
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
BACKGROUND: Non‐absorbable disaccharides (lactulose and lactitol) are recommended as first‐line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non‐absorbable disaccharides versus placebo/no intervention and...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2016
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004252/ https://ncbi.nlm.nih.gov/pubmed/27153247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003044.pub4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|